As governments seek to mitigate the cost of state subsidized healthcare, branding in the pharmaceutical industry has become a critical issue. Drugs companies must change their methods of communication and distribution focusing more on their direct relationship with the consumer. This requires fundamental changes in consumer behaviour, access to information, freedom of choice and value for money. Brands and brand values will play a leading role in this process, as has been seen with products such as Prozac and Viagra. This book by Interbrand Newell and Sorrell provides thinking on branding for the pharmaceutical industry and lessons for anyone involved in brand development and management.
Edited by:
T. Blackett, R. Robins, Tom Blackett, Rebecca Robins Imprint: Palgrave Macmillan Country of Publication: United Kingdom Dimensions:
Height: 229mm,
Width: 152mm,
Spine: 25mm
Weight: 638g ISBN:9780333930984 ISBN 10: 0333930983 Pages: 308 Publication Date:27 April 2001 Audience:
College/higher education
,
Professional and scholarly
,
Professional & Vocational
,
A / AS level
,
Further / Higher Education
Format:Hardback Publisher's Status: Active
TOM BLACKETT is Group Deputy Chairman of Interbrand Newell and Sorrell. He is the author of, Trademarks and the co-author of, Co-Branding, both published by Palgrave. - REBECCA ROBINS works for Interbrand Newell and Sorrell